X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-08-30 | BLK | Wiedman Mark | Senior MD | S - Sale+OE | $900.00 | -12,000 | 6,480 | -65% | -$10,800,000 | |||||
D | 2024-08-29 | BLK | Kushel J. Richard | Senior MD | S - Sale+OE | $888.92 | -14,000 | 144,410 | -9% | -$12,444,914 | |||||
D | 2024-08-15 | BLK | Wiedman Mark | Senior MD | S - Sale+OE | $875.04 | -12,000 | 6,480 | -65% | -$10,500,415 | |||||
DM | 2024-08-12 | BLK | Wiedman Mark | Senior MD | S - Sale+OE | $852.72 | -12,000 | 6,480 | -65% | -$10,232,680 | |||||
2024-08-06 | BLK | Fink Laurence | COB, CEO | S - Sale | $843.25 | -29,450 | 343,790 | -8% | -$24,833,598 | ||||||
2024-08-02 | BLK | Daley Pamela | Dir | S - Sale | $842.08 | -1,531 | 5,732 | -21% | -$1,289,218 | ||||||
D | 2024-07-16 | BLK | Wiedman Mark | Senior MD | S - Sale+OE | $834.42 | -27,000 | 6,480 | -81% | -$22,529,395 | |||||
2024-05-20 | BLK | Fink Laurence | COB, CEO | S - Sale | $807.29 | -30,978 | 383,168 | -7% | -$25,008,124 | ||||||
D | 2024-05-10 | BLK | Wiedman Mark | Senior MD | S - Sale+OE | $795.00 | -9,000 | 6,480 | -58% | -$7,155,000 | |||||
2024-02-28 | BLK | Fink Laurence | COB, CEO | S - Sale | $809.92 | -30,978 | 414,146 | -7% | -$25,089,571 | ||||||
D | 2024-02-23 | BLK | Lord Rachel | Senior MD | S - Sale+OE | $818.06 | -36,059 | 17,004 | -68% | -$29,498,473 | |||||
2024-02-23 | BLK | Wiedman Mark | Senior MD | S - Sale | $821.69 | -240 | 6,480 | -4% | -$197,207 | ||||||
2024-02-12 | BLK | Cohen Stephen | Senior MD | S - Sale | $805.55 | -950 | 4,437 | -18% | -$765,273 | ||||||
2024-02-07 | BLK | Meade Christopher J. | GC, CLO | S - Sale | $793.86 | -3,100 | 8,628 | -26% | -$2,460,979 | ||||||
2024-02-05 | BLK | Kushel J. Richard | Senior MD | S - Sale | $784.69 | -520 | 144,410 | 0% | -$408,037 | ||||||
2024-02-05 | BLK | Comerchero Marc D. | Principal Accounting Officer | S - Sale | $785.11 | -450 | 5,975 | -7% | -$353,297 | ||||||
M | 2024-02-01 | BLK | Kushel J. Richard | Senior MD | S - Sale | $786.40 | -6,689 | 144,930 | -4% | -$5,260,199 | |||||
2024-02-02 | BLK | Wiedman Mark | Senior MD | S - Sale | $788.73 | -2,500 | 7,859 | -24% | -$1,971,829 | ||||||
2024-02-02 | BLK | Small Martin | CFO, Senior MD | S - Sale | $786.36 | -7,036 | 5,259 | -57% | -$5,532,806 | ||||||
D | 2024-01-22 | BLK | Meade Christopher J. | GC, CLO | S - Sale+OE | $796.04 | -18,000 | 11,914 | -60% | -$14,328,661 | |||||
2023-11-06 | BLK | Fink Laurence | COB, CEO | S - Sale | $652.03 | -15,385 | 435,260 | -3% | -$10,031,416 | ||||||
2023-07-26 | BLK | Fink Laurence | COB, CEO | S - Sale | $742.04 | -20,200 | 450,645 | -4% | -$14,989,297 | ||||||
2023-07-18 | BLK | Wiedman Mark | Senior MD | S - Sale | $733.82 | -2,079 | 6,160 | -25% | -$1,525,618 | ||||||
2023-04-18 | BLK | Fink Laurence | COB, CEO | S - Sale | $694.50 | -35,799 | 484,325 | -7% | -$24,862,480 | ||||||
2023-04-17 | BLK | Kushel J. Richard | Senior MD | S - Sale | $696.00 | -3,000 | 149,130 | -2% | -$2,087,993 | ||||||
2023-02-27 | BLK | Kushel J. Richard | Senior MD | S - Sale | $689.06 | -575 | 152,130 | 0% | -$396,208 | ||||||
2023-02-09 | BLK | Comerchero Marc D. | Principal Accounting Officer | S - Sale | $728.66 | -650 | 3,055 | -18% | -$473,631 | ||||||
2023-02-07 | BLK | Kushel J. Richard | Senior MD | S - Sale | $742.31 | -1,000 | 152,705 | -1% | -$742,310 | ||||||
2023-02-03 | BLK | Cohen Stephen | Senior MD | S - Sale | $756.26 | -390 | 4,357 | -8% | -$294,941 | ||||||
M | 2023-02-02 | BLK | Wiedman Mark | Senior MD | S - Sale | $762.70 | -3,233 | 8,239 | -28% | -$2,465,806 | |||||
M | 2023-02-02 | BLK | Kushel J. Richard | Senior MD | S - Sale | $766.82 | -4,807 | 153,705 | -3% | -$3,686,089 | |||||
2023-01-30 | BLK | Cohen Stephen | Senior MD | S - Sale | $753.46 | -1,149 | 4,135 | -22% | -$865,726 | ||||||
2023-01-18 | BLK | Wiedman Mark | Senior MD | S - Sale | $749.89 | -1,075 | 8,682 | -11% | -$806,133 | ||||||
2022-11-22 | BLK | Fink Laurence | COB, CEO | S - Sale | $732.25 | -40,960 | 507,381 | -7% | -$29,992,925 | ||||||
2022-11-15 | BLK | Mehta Manish | Senior MD | S - Sale | $742.81 | -1,350 | 10,059 | -12% | -$1,002,791 | ||||||
2022-11-11 | BLK | Lord Rachel | Senior MD | S - Sale | $773.41 | -3,950 | 8,319 | -32% | -$3,054,956 | ||||||
2022-11-11 | BLK | Wiedman Mark | Senior MD | S - Sale | $781.11 | -2,100 | 9,389 | -18% | -$1,640,323 | ||||||
2022-11-11 | BLK | McCombe Mark | Senior MD | S - Sale | $770.55 | -1,000 | 20,106 | -5% | -$770,554 | ||||||
2022-11-08 | BLK | Fink Laurence | COB, CEO | S - Sale | $685.58 | -14,600 | 549,171 | -3% | -$10,009,526 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |